If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

Share Price is delayed by 15 minutes
Get Live Data
2,520.00    -73.00 (-2.82%)
Bid:
2,524.00
Ask:
2,526.00
Spread: 2.00 (0.079%)
Market Cap: £7.50b
SMIN Live PriceLast checked at - London Stock Exchange

Intraday Smiths Group Share Chart

Agreement

20 Feb 2026 09:45

RNS Number : 8454T
Smiths Group PLC
20 February 2026
 

20 February 2026

SMITHS GROUP PLCSMITHS SIGNS BINDING AGREEMENT TO SELL SMITHS DETECTION TO CVC

Further to the announcement on 3 December 2025, Smiths Group plc (Smiths) announces that it has now entered into a binding share purchase agreement (the SPA) for the sale of Smiths Detection to CVC Capital Partners (CVC) (the Transaction). As announced previously, the Transaction values Smiths Detection at an enterprise value of £2.0 billion[1], representing 16.3x headline operating profit of £122 million and 12.5x headline EBITDA of £160 million for the financial year ending 31 July 2025. At completion of the Transaction, Smiths is expected to receive approximately £1.85 billion in net cash proceeds (after accounting for related transaction expenses and separation costs), subject to customary adjustments by virtue of the locked box accounts mechanism in the SPA.

Smiths announced on 3 December 2025 that it had entered into a put option deed (the Put Option) with CVC. Pursuant to the Put Option, following the completion of an information and consultation process with the works council of Smiths Detection France SAS, Smiths has exercised the Put Option and has now entered into the SPA with CVC for the sale of Smiths Detection.

The Transaction remains subject to the satisfaction of customary regulatory approvals. All regulatory filings required under the SPA have now been made, and clearances from certain regulatory authorities have already been received. As previously announced, the completion of the Transaction is expected in the second half of calendar year 2026.

ENDS

IR contacts

Siobhán Andrews, Smiths Group

+44 (0) 7920 230093 

siobhan.andrews@smiths.com

Ana Pita da Veiga, Smiths Group

+44 (0)7386 689442

ana.pitadaveiga@smiths.com

Media contacts

Tom Steiner, Smiths Group 

+44 (0)7787415891 

tom.steiner@smiths.com

Alex Le May, FTI Consulting 

+44 (0) 2037271340

smiths@fticonsulting.com

Company Secretary

Matthew Whyte

+44 (0) 7775 982879 

matthew.whyte@smiths.com

About Smiths Group

For 175 years, we have been pioneers of progress, engineering a better future. Our strategy is to be a focused, efficient and value creating industrial engineering company operating within markets aligned to attractive, long-term growth drivers notably energy, industrials, construction and aerospace.

We focus on solving the toughest problems for our customers, helping address critical global needs such as the ever-increasing demand for process and energy efficiency, and decarbonisation. Listed on the London Stock Exchange, we are present in over 50 countries worldwide. For more, visit www.smiths.com.

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11


[1] The enterprise value of Smiths Detection is stated on a debt free, cash free basis and before taking into account any adjustments required under the terms of the Transaction, tax, and associated transaction costs.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRKBLBLQLLLBBE
Date   Source Headline
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme
26th Mar 20247:01 amRNSSmiths Group half year results
26th Mar 20247:00 amRNSDirectorate Change
1st Mar 20247:00 amRNSSmiths sells 830,000 shares in ICU Medical Inc
29th Feb 20249:00 amRNSDirectors' Change in Responsibilities
1st Feb 202410:15 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirectors' Change in Responsibilities
30th Nov 20237:00 amRNSSmiths Group plc - John Crane deep dive
16th Nov 20231:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSSmiths Group plc - Q1 Trading Update
2nd Nov 20232:45 pmRNSDirector/PDMR Shareholding
1st Nov 202310:00 amRNSBlock listing Interim Review
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:25 pmRNSDirector/PDMR Shareholding
12th Oct 202312:35 pmRNSAnnual Financial Report and AGM 2023
4th Oct 202310:00 amRNSDirector/PDMR Shareholding
2nd Oct 202312:10 pmRNSTotal Voting Rights
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSSmiths Group FY23 Full Year Results
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.